natural progression of atherosclerotic disease
Showing 1 - 25 of >10,000
Natural History of Coronary Atherosclerosis
Not yet recruiting
- Coronary Artery Disease Progression
- +3 more
- (no location specified)
Sep 13, 2023
Facioscapulohumeral Muscular Dystrophy Type 2 Trial in France, Italy, Spain (Validation of new COMs for FSHD2 patients)
Recruiting
- Facioscapulohumeral Muscular Dystrophy Type 2
- Validation of new COMs for FSHD2 patients
-
Nice, Alpes M, France
- +5 more
Oct 6, 2023
Prediction of Atherosclerotic Plaque Progression
Active, not recruiting
- Coronary Artery Disease
- OCT, NIRS
-
Prague, CzechiaNa Homolce Hospital
Jun 15, 2022
Long-Term Neurologic Sequelae of Ebola Virus Disease Survivors
Recruiting
- Ebola Virus Disease
-
Monrovia, LiberiaJohn F. Kennedy Medical Center
Aug 17, 2022
Natural History Study of Patients With VCP-related Disease
Recruiting
- IBMPFD
-
Columbus, OhioNationwide Children's Hospital
Jul 29, 2022
Peripheral Arterial Disease, Peripheral Vascular Diseases, Catheterization, Peripheral Trial in United States (NVS Therapy)
Completed
- Peripheral Arterial Disease
- +2 more
- NVS Therapy
-
Houma, Louisiana
- +3 more
Jul 13, 2022
Coronary Artery Disease Progression Trial (Intensive lipid-lowering control, Moderate-intensity lipid-lowering control)
Not yet recruiting
- Coronary Artery Disease Progression
- Intensive lipid-lowering control
- Moderate-intensity lipid-lowering control
- (no location specified)
Jul 13, 2022
Familial Hypereosinophilia: Natural History and Markers of
Recruiting
- Eosinophilia
- Hypereosinophilic Syndrome
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022
Coronary Artery Disease, Coronary Artery Stenosis, Coronary Artery Restenosis Trial (behavioral, drug, procedure)
Not yet recruiting
- Coronary Artery Disease
- +6 more
- Healthy life style
- +4 more
- (no location specified)
May 8, 2023
Critical Limb Ischemia, Peripheral Artery Disease Trial in Gainesville
Active, not recruiting
- Critical Limb Ischemia
- Peripheral Artery Disease
-
Gainesville, FloridaThe Cardiac and Vascular Institute
Apr 7, 2022
Natural Disease Progression in Participants With Choroideremia
Completed
- Choroideremia
- No Intervention
-
San Francisco, CaliforniaResearch Site
Sep 7, 2021
Coronary Artery Disease, Diabetes, Type 2, Dyslipidemias Trial in Shanghai
Recruiting
- Coronary Artery Disease
- +4 more
-
Shanghai, ChinaRuijin Hospital, Shanghai Jiaotong University School of Medicine
Nov 1, 2021
Periodontal Disease, Inflammation and Acute Coronary Syndromes
Completed
- Coronary Stenosis
- +7 more
- cardiac imaging tests
-
Târgu-Mureş, Mures, RomaniaCardio Med
Jul 30, 2022
Ataxia Trial in Worldwide (Clinical rating scale to measure ataxia disease severity and progression)
Recruiting
- Ataxia
- Clinical rating scale to measure ataxia disease severity and progression
-
Melbourne, Victoria, Australia
- +9 more
Jul 12, 2022
Multiple System Atrophy Trial in France (MRI acquisition, DAT-SPECT, blood sample, cerebrospinal fluid (optional))
Active, not recruiting
- Multiple System Atrophy
- MRI acquisition
- +4 more
-
Bordeaux, France
- +9 more
Oct 11, 2021
Coronary Artery Disease, Atherosclerosis, Coronary, Hiv Trial in Moscow (Quantitative coronary angiography, intravascular
Enrolling by invitation
- Coronary Artery Disease
- +4 more
- Quantitative coronary angiography, intravascular imaging with percutaneous intervention
-
Moscow, Russian Federation
- +1 more
Mar 12, 2022
A Retrospective, Natural History Study in Children With CLN2
Withdrawn
- Late-infantile Neuronal Ceroid Lipofuscinosis Type 2 (CLN2)
- (no location specified)
Oct 25, 2021
Neuronal Ceroid Lipofuscinosis, Batten Disease, CLN1 Disease Trial in Hamburg (Natural History)
Recruiting
- Neuronal Ceroid Lipofuscinosis
- +14 more
- Natural History
-
Hamburg, GermanyUniversity Medical Center Hamburg-Eppendorf
Oct 22, 2021
Limb Girdle Muscular Dystrophy Type 2A and Type 2E
Recruiting
- Limb-Girdle Muscular Dystrophy Type 2A
- Limb-Girdle Muscular Dystrophy, Type 2E
-
Columbus, OhioNationwide Children's Hospital
Dec 6, 2021
Coronary Artery Disease Trial in Worldwide (Inclisiran sodium 300 mg, Placebo)
Recruiting
- Coronary Artery Disease
- Inclisiran sodium 300 mg
- Placebo
-
Huntsville, Alabama
- +54 more
Jan 31, 2023
Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Sarcoidosis Trial in Charlottesville (Interstitial Lung Disease)
Enrolling by invitation
- Interstitial Lung Disease
- +5 more
- Interstitial Lung Disease
-
Charlottesville, VirginiaUniversity of Virginia Health System
May 20, 2021
Coronary Chronic Total Occlusion and Oxidative Balance
Completed
- Progression of Atherosclerotic Plaque
- Coronary Artery Disease
- Comparison of oxidative and antioxidative markers between groups
-
Kahramanmaraş, TurkeyEkrem Aksu
Feb 12, 2021
Muramyl Dipeptide in Intestinal and Extra-intestinal Diseases
Recruiting
- Colorectal Cancer
- +3 more
- Observational studies, no intervention
-
Guangzhou, Guang Dong, ChinaZhujiang hospital
Jun 10, 2021
Autosomal Dominant Retinitis Pigmentosa (adRP)
Terminated
- Retinitis Pigmentosa
- Observation
-
Dallas, TexasTexas Retina Associates,
Mar 15, 2021
Long-term Evaluation
Recruiting
- Atherosclerosis
- +3 more
- PET imaging
- +2 more
-
Cambridge, United KingdomUniversity of Cambridge
Mar 18, 2022